Steven Liggett

CEO, Future Medicines Institute (FMI), Belfast

Steven Liggett is CEO of the Future Medicines Institute in Belfast, where he is leading a bold vision to bridge the translational gap between early innovation and clinical impact. At the heart of FMI’s mission is enabling smarter, faster routes to medicine — by aligning scientific discovery with the realities of development, regulation, and patient access.

Steven brings extensive regulatory and clinical development experience from his years at ICON plc, one of the world’s largest CROs. At ICON, he played a key role in navigating complex global regulatory landscapes and supporting biotech and pharma partners through critical development milestones.

Now at FMI, Steven leverages that depth of expertise to foster cross-sector collaboration, shape regulatory-ready innovation environments, and position Belfast as a leading hub for future-facing therapeutic development.

With a rare blend of strategic insight, operational experience, and regulatory know-how, Steven is committed to helping the next generation of medicines move from idea to patient — with greater speed, confidence, and purpose.